| Name | Title | Contact Details |
|---|
TRIMEDX is a technology-enabled, clinical asset management company, anchored on a strong foundation of clinical engineering, exclusively serving the healthcare community. As the largest independent technology-enabled clinical asset management company in the U.S., TRIMEDX provides strategic planning for - and management of - clinical assets to drive reductions in operational expenses, free up capital for new strategic initiatives, and deliver improved safety and cyber protection. Headquartered in Indianapolis, Indiana, TRIMEDX was built by providers, for providers, and leverages a history of expert clinical engineering to manage over $30 billion in clinical assets across thousands of locations. Our programs include flexible, yet comprehensive management of all patient-based technology, including biomedical, imaging, laboratory, and specialty equipment. Key features of our programs include: • Client Experience Center • Parts and Service Procurement Center • Regulatory Compliance Team • Computerized Maintenance Management System • Equipment Lifecycle Management In September of 2012, TRIMEDX was recognized by Modern Healthcare Magazine as the #1 Clinical Equipment Maintenance Contractor.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Northern Arizona Regional Behavioral Health Authority (NARBHA) was founded in 1967. It is a private, not-for-profit managed care corporation designated by the Arizona Department of Health Services as being responsible for the planning, implementation, funding, monitoring and administration of publicly funded comprehensive behavioral health services in Northern Arizona. NARBHA serves over 700,000 people throughout 62,000 square miles (or ½ of the state) of northern Arizona, including the Hopi Reservation. NARBHA subcontracts with ten Responsible Agencies (RAs), over 70 additional behavioral health providers, and operated under Memorandums of Understanding (MOU) with ten Native American tribes, offering choice of services to members throughout northern Arizona. NARBHA contracts with NAZCARE, Recovery Innovations of Arizona (RIAZ), and MIKID to offer peer and family support programs and services. Consumer/ family involvement is included on eight standing NARBHA and numerous ad hoc NARBHA Committees and Workgroups.
Sports Facility | Whitesboro, NY
Midwest Medical Staffing is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.